📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
30 announcements match the current filters (relevance ≥ 5).
Paradeep Phosphates Q3 PAT at ₹182 Cr; N Suresh Krishnan Re-appointed as MD & CEO
Paradeep Phosphates reported a 15.2% year-on-year increase in revenue to ₹5,748.67 crore for Q3 FY26. However, quarterly net profit declined to ₹182.05 crore from ₹209.28 crore in the previous year, primarily due to an exceptional item of ₹41.30 crore. On a nine-month basis, the company showed robust growth with PAT reaching ₹841.24 crore, up from ₹490.66 crore. The board also confirmed key leadership roles, re-appointing N Suresh Krishnan as MD & CEO and appointing K K Rajeev Nambiar as Joint MD.
Key Highlights
Revenue from operations increased to ₹5,748.67 crore in Q3 FY26 vs ₹4,989.55 crore in Q3 FY25.
Net profit for the quarter stood at ₹182.05 crore, impacted by a ₹41.30 crore exceptional charge.
9M FY26 PAT surged 71.4% to ₹841.24 crore compared to ₹490.66 crore in the previous year period.
N Suresh Krishnan re-appointed as MD & CEO for 3 years effective February 16, 2026.
Financial results reflect the merger with Mangalore Chemicals & Fertilizers Limited (MCFL) effective April 1, 2024.
👀 What to Watch
Investors should focus on the strong nine-month growth trajectory and the successful integration of MCFL, while keeping an eye on the impact of exceptional items on quarterly margins. The leadership continuity is a positive sign for long-term strategic execution.
Paradeep Phosphates Q3 PAT at ₹182 Cr; Appoints K K Rajeev Nambiar as Joint MD
Paradeep Phosphates reported a 15.2% YoY increase in standalone revenue to ₹5,748.67 crore for Q3 FY26. However, quarterly net profit declined to ₹182.05 crore from ₹209.28 crore in the previous year, primarily due to an exceptional item of ₹41.30 crore. The nine-month performance remains robust, with PAT surging 71% to ₹841.24 crore compared to ₹490.66 crore in the same period last year. The company also announced leadership changes, including the re-appointment of N Suresh Krishnan as MD and the appointment of K K Rajeev Nambiar as Joint MD.
Key Highlights
Revenue from operations for Q3 FY26 stood at ₹5,748.67 crore, up from ₹4,989.55 crore YoY.
Net profit for the nine months ended Dec 2025 reached ₹841.24 crore, a significant jump from ₹490.66 crore YoY.
Quarterly PAT was impacted by an exceptional charge of ₹41.30 crore, resulting in a YoY dip to ₹182.05 crore.
Mr. N Suresh Krishnan re-appointed as MD for 3 years; Mr. K K Rajeev Nambiar appointed as Joint MD starting April 2026.
Financial results incorporate the retrospective impact of the MCFL merger effective from April 1, 2024.
👀 What to Watch
Investors should look past the quarterly PAT dip caused by exceptional items and focus on the strong nine-month growth and successful MCFL integration. The strengthening of the top management team suggests a focus on long-term operational excellence.
Paradeep Phosphates Q3 PAT at ₹182 Cr; Re-appoints MD and Appoints New Joint MD
Paradeep Phosphates reported a revenue of ₹5,748.67 crore for Q3 FY26, a 15.2% increase compared to ₹4,989.55 crore in the same quarter last year. However, Net Profit for the quarter declined to ₹182.05 crore from ₹209.28 crore, primarily impacted by an exceptional item of ₹41.30 crore. On a nine-month basis, the company showed robust growth with PAT rising to ₹841.24 crore from ₹490.66 crore. The board also approved key leadership changes, including the re-appointment of N Suresh Krishnan as MD and the appointment of K K Rajeev Nambiar as Joint MD.
Key Highlights
Revenue from operations grew 15.2% YoY to ₹5,748.67 crore in Q3 FY26.
Net Profit for Q3 FY26 stood at ₹182.05 crore, down 13% YoY, affected by a ₹41.30 crore exceptional charge.
9-month PAT saw a significant jump of 71.4% to ₹841.24 crore compared to ₹490.66 crore in the previous year.
N Suresh Krishnan re-appointed as MD for 3 years; K K Rajeev Nambiar appointed as Joint MD.
Financials include the retrospective impact of the Mangalore Chemicals & Fertilizers Limited (MCFL) merger effective April 1, 2024.
👀 What to Watch
Investors should focus on the strong 9-month growth trajectory and the long-term synergies expected from the MCFL merger despite the quarterly profit dip. The leadership continuity and expansion of the management team are positive signs for operational stability.
Paradeep Phosphates Q3 PAT Falls 13% YoY to ₹182 Cr; 9M Profit Surges 71% to ₹841 Cr
Paradeep Phosphates reported a 15.2% YoY increase in revenue to ₹5,748.67 crore for Q3 FY26, though net profit declined by 13% to ₹182.05 crore due to an exceptional loss of ₹41.30 crore. On a nine-month basis, the company showed strong performance with PAT rising 71.4% to ₹841.24 crore compared to the previous year. The financials reflect the impact of the completed merger with Mangalore Chemicals & Fertilizers Limited (MCFL), with figures restated from April 2024. Additionally, the board approved the re-appointment of N Suresh Krishnan as MD and the appointment of K K Rajeev Nambiar as Joint MD.
Key Highlights
Revenue from operations grew 15.2% YoY to ₹5,748.67 crore in Q3 FY26.
Net profit for Q3 FY26 stood at ₹182.05 crore, down from ₹209.28 crore in the same period last year.
9M FY26 PAT surged 71.4% YoY to ₹841.24 crore, driven by the MCFL merger integration.
Board approved re-appointment of N Suresh Krishnan as MD and K K Rajeev Nambiar as Joint MD for 3-year terms.
Financials include an exceptional loss of ₹41.30 crore during the quarter.
👀 What to Watch
Investors should monitor the synergy benefits from the MCFL merger which are driving the strong 9M growth, despite the quarterly volatility. The management continuity with the MD's re-appointment provides stability for long-term strategy.
Paradeep Phosphates Credit Rating Upgraded to [ICRA]AA- (Stable) for ₹6,000 Cr Long-term Debt
ICRA Limited has upgraded the credit ratings for Paradeep Phosphates Limited's bank facilities and instruments totaling over ₹17,500 crores. The long-term ratings for ₹6,000 crores in fund-based facilities (Cash Credit and Term Loans) moved from [ICRA]A+ to [ICRA]AA- with a Stable outlook. Short-term ratings for ₹11,200 crores in non-fund based facilities and ₹300 crores in commercial paper were also upgraded to the highest category of [ICRA]A1+. This upgrade reflects improved financial stability and creditworthiness, which could potentially lead to lower borrowing costs for the company.
Key Highlights
Long-term rating for ₹3,000 crore Cash Credit upgraded to [ICRA]AA- from [ICRA]A+
Long-term rating for ₹3,000 crore Term Loan upgraded to [ICRA]AA- with a Stable outlook
Short-term rating for ₹11,200 crore Non-fund based facilities upgraded to [ICRA]A1+
Commercial Paper rating for ₹300 crore upgraded to [ICRA]A1+
Ratings removed from 'Watch with developing implications' status to 'Stable' outlook
👀 What to Watch
Investors should view this as a positive signal of the company's strengthening balance sheet and reduced credit risk. Monitor the upcoming quarterly results to see if the improved rating translates into lower interest expenses.
Paradeep Phosphates Faces Seizure of Rs 103.30 Cr Urea Consignment by Customs
Paradeep Phosphates has received a Seizure Memo from the Commissioner of Customs, Goa, for 25,000 MTs of Technical Grade Urea valued at Rs 103.30 crores. The seizure is based on a test report alleging that the Biuret content in the imported goods exceeds permissible limits, potentially violating DGFT and Foreign Trade Policy norms. The company is currently contesting the testing methodology used by the Central Revenues Control Laboratory and is seeking a re-test under specific Indian Standards. While the company states there is no immediate material impact on operations, it is pursuing legal recourse for the provisional release of the inventory for its Goa plant.
Key Highlights
Seizure of 25,000 MTs of Technical Grade Urea with an assessable value of Rs 103.30 crores
Alleged violation of DGFT notification No. 79/2015-2020 and Foreign Trade Policy provisions
Company is contesting the CRCL testing methodology and demanding re-testing per IS 1781: 2022 standards
Legal action initiated for provisional release of goods for captive consumption at the Goa manufacturing facility
👀 What to Watch
Investors should monitor the legal proceedings and re-testing results, as a final adverse ruling could lead to inventory write-offs or penalties. The situation is currently a regulatory hurdle rather than an operational shutdown, but the high value of the seized goods warrants caution.
Paradeep Phosphates Seeks Approval to Increase Borrowing Limit to ₹20,000 Crore
Paradeep Phosphates Limited has issued a postal ballot notice seeking shareholder approval for a significant increase in its borrowing capacity to ₹20,000 crore. This new limit, which supersedes the 2022 resolution, is intended to fund working capital, capital asset acquisitions, and other business requirements through various debt instruments. The company is also seeking ratification for the cost auditor's remuneration of ₹5 lakh and the appointment of Mr. Akshay Poddar as a Non-Executive Director. E-voting for these resolutions will take place between January 4 and February 2, 2026.
Key Highlights
Proposed increase in borrowing limit to ₹20,000 crore, including loans, debentures, and foreign currency bonds.
Authorization sought to create mortgages or charges on company assets to secure the expanded debt limits.
Ratification of ₹5,00,000 remuneration for Cost Auditor M/s. S. S. Sonthalia & Co. for FY 2025-26.
Appointment of Mr. Akshay Poddar as a Non-Executive Director to the Board.
Remote e-voting period scheduled from January 4, 2026, to February 2, 2026.
👀 What to Watch
Investors should monitor the company's upcoming capital expenditure plans and leverage levels, as the massive increase in borrowing capacity suggests major expansion or acquisition plans. The appointment of a promoter-group director indicates continued strategic alignment with the Adventz Group.
Paradeep Phosphates Lists 22.16 Cr New Shares Following Merger with MCFL
Paradeep Phosphates Limited has received trading approval for 22,16,23,331 new equity shares of Rs. 10 each. These shares were allotted to shareholders of Mangalore Chemicals & Fertilizers Limited (MCFL) as part of the court-approved Scheme of Amalgamation. The approval was granted by both NSE and BSE on December 30, 2025. This marks the final procedural step in the merger process, effectively consolidating the two fertilizer businesses under one listed entity.
Key Highlights
Listing of 22,16,23,331 new equity shares of face value Rs. 10 each.
Trading approval received from NSE and BSE on December 30, 2025.
Shares issued pursuant to the Scheme of Amalgamation with Mangalore Chemicals & Fertilizers Limited.
The move completes the formal integration of the two entities into Paradeep Phosphates.
👀 What to Watch
Investors should monitor the combined entity's quarterly performance to assess synergy benefits and the impact of equity dilution on Earnings Per Share (EPS). Existing MCFL shareholders should check their demat accounts for the credited Paradeep shares.
Paradeep Phosphates to Enter Power Generation; Amends MOA Object Clause
Paradeep Phosphates Limited has approved an amendment to its Memorandum of Association (MOA) to include power generation and distribution as a main business object. The company intends to generate, purchase, and sell electrical energy from both conventional and non-conventional sources, including waste heat recovery systems. This strategic move allows the company to supply surplus power to state utilities and open market buyers, potentially creating a new revenue stream. The amendment also aligns the company's MOA with the Companies Act, 2013, and is currently subject to shareholder approval.
Key Highlights
Board approved insertion of sub-clause (iv) in Clause III(A) to permit power generation and distribution activities.
Focus on utilizing waste heat recovery systems to improve operational efficiency and energy self-sufficiency.
Authorization to sell surplus power to State utilities and open market buyers under applicable regulations.
Adoption of a new set of MOA to ensure full compliance with the Companies Act, 2013.
Decision taken via circular resolution on December 31, 2025, pending shareholder ratification.
👀 What to Watch
Investors should view this as a positive long-term strategic shift that could lower energy costs and diversify revenue. Monitor future CAPEX announcements related to power infrastructure and waste heat recovery projects.
Paradeep Phosphates Allots 22.16 Cr Shares for Merger with Mangalore Chemicals
Paradeep Phosphates Limited (PPL) has approved the allotment of 22,16,23,331 equity shares to the shareholders of Mangalore Chemicals & Fertilizers Limited (MCFL) as part of a composite scheme of arrangement. The allotment follows a share exchange ratio of 187 PPL shares for every 100 MCFL shares held as of the October 31, 2025 record date. This move significantly expands PPL's capital base, with the total paid-up equity increasing from ₹816.35 crore to ₹1,037.97 crore. The new shares will be listed on the BSE and NSE following necessary regulatory approvals.
Key Highlights
Allotment of 22,16,23,331 equity shares of face value ₹10 each to MCFL shareholders.
Share exchange ratio fixed at 187 fully paid-up shares of PPL for every 100 shares of MCFL.
Total paid-up equity capital increased from ₹816.35 crore to ₹1,037.97 crore, a rise of approximately 27%.
35,43,365 shares allotted to 'PPL Merger Trust' for physical shareholders and 23,219 shares for fractional entitlements.
The newly allotted shares will be listed on both BSE and NSE post-regulatory clearance.
👀 What to Watch
Investors should monitor the integration of MCFL's operations into Paradeep Phosphates and the resulting impact on earnings per share (EPS) due to the 27% increase in equity capital. Former MCFL shareholders should check their demat accounts for the credit of new shares.
